Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;233(1):79-86.
doi: 10.1016/j.expneurol.2011.09.035. Epub 2011 Oct 6.

Stress, depression and Parkinson's disease

Affiliations
Review

Stress, depression and Parkinson's disease

Ann M Hemmerle et al. Exp Neurol. 2012 Jan.

Abstract

In this review, we focus on the relationship among Parkinson's disease (PD), stress and depression. Parkinson's disease patients have a high risk of developing depression, and it is possible that stress contributes to the development of both pathologies. Stress dysfunction may have a role in the etiology of preclinical non-motor symptoms of PD (such as depression) and, later in the course of the disease, may worsen motor symptoms. However, relatively few studies have examined stress or depression and the injured nigrostriatal system. This review discusses the effects of stress on neurodegeneration and depression, and their association with the symptoms and progression of PD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Molecular and cellular effects of chronic stress
Chronic stress may impair neurons via several mechanisms. Chronic activation of the HPA axis results in hyperactive activation of the axis and increased levels of relevant hormones including corticotrophin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), circulating glucocorticoids and impairment of dexamethasone feedback (Herman et al., 1995; Mizoguchi et al., 2008; Ulrich-Lai and Herman; 2009). Chronic stress results in an increased neuroinflammatory environment via increases in pro-inflammatory molecules such as interleukin-6 (IL-6), IL-1, tumor necrosis factor alpha (TNFα), and nuclear factor kappa B (NF-κB) and decreases in anti-inflammatory molecules such as IL-10 and transforming growth factor beta (TGFβ) (Grippo et al., 2005; You et al, 2011; Sun et al., 2011). Neurodegeneration increases in the hippocampus after chronic stress at least partly due to increased caspase-3 levels and decreased anti-apoptotic B-cell lymphoma (Bcl-2) levels (Bachis et al., 2008; Kosten et al., 2008; Yang et al., 2011). Dendritic atrophy occurs in several regions including the hippocampus and prefrontal cortex (Magariños and McEwen, 1995a, b; Wellman, 2001; Radley 2004; Cerqueira et al., 2005). Cellular oxidative stress also changes after chronic stress including increases in the superoxide radical O2- and protein and lipid peroxidation (Lucca et al., 2009a, b; Ahmad et al., 2010; Tagliari et al., 2010). Loss of trophic support through decreases in brain-derived neurotrophic factor (BDNF) occurs in the hippocampus and prefrontal cortex after chronic stress (Smith et al., 1995; Song et al., 2006; Adzic et al., 2009). Lastly, chronic stress decreases neurogenesis in the hippocampus as indicated by the loss of bromodeoxyuridine (BrdU) positive cells (Gould and Tanapat, 1999; Pham et al., 2003). Together, these stress-induced cellular and molecular alterations create a harmful neuronal environment that could result in the presentation of depressive and other neuropsychiatric symptoms.

Similar articles

Cited by

References

    1. Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord. 2009;24:2175–2186. - PMC - PubMed
    1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem. 1989;52:1655–1658. - PubMed
    1. Adzic M, Djordjevic J, Djordjevic A, Niciforovic A, Demonacos C, Radojcic M, Krstic-Demonacos M. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J Endocrinol. 2009;202:87–97. - PMC - PubMed
    1. Ahima RS, Harlan RE. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience. 1990;39:579–604. - PubMed
    1. Ahmad A, Rasheed N, Banu N, Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress. 2010;13:355–364. - PubMed

Publication types

MeSH terms